We combined the amplification refractory mutation system (ARMS ) and fluorescence polarization (FP) to give a homogeneous genomic DNA genotype analysis method. Oligonucleotide probes labeled with the fluorescein dyes fluorescein isothiocyanate and 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein and the rhodamine dye 6-carboxyrhodamine were included in amplification mixes and were annealed to PCR products after amplification. Hybridization was accompanied by an increase in the FP of the probe. We demonstrated homogeneous genotyping by analyzing human DNA samples for ⌬F 508 mutation status of the cystic fibrosis transmembrane conductance regulator gene. The genotypes determined with the method described herein were in full agreement with those obtained by the conventional application of ARMS. We also demonstrated the simultaneous detection of two PCR products in a single reaction. The assay method described is homogeneous and so obviates the necessity to open reaction vessels after amplification. This therefore eliminates PCR carryover contamination.
PCR is the cornerstone of several DNA diagnostic methods. These may be applied to the detection of microbial and viral contamination and infections, to the diagnosis of human inherited diseases, to predispositions to pathological states, and to the screening for cancers and residual disease after therapy [1, 2] . During PCR, an enrichment of the DNA target by 10 10 -10 12 -fold is routinely achieved. Because the products of a reaction become the substrates in subsequent cycles of amplification with the same primer system, it is essential that there be no crossover contamination of amplicon to subsequent unamplified reaction mixes; otherwise, false-positive results will be generated.
Crossover contamination prevention is usually addressed by isolating each stage of the PCR process so that setup, amplification, and detection are carried out in separate facilities with dedicated protective clothing and equipment for each area [3] . Another physical precaution is the use of laminar airflows [3] . Biochemical means of preventing PCR product carryover contamination include UV photoinactivation after psoralen [4 -6] or isopsoralen [7] [8] [9] treatment, or more commonly, substitution of dUTP for dTTP during PCR with subsequent PCRs being pretreated with uracil DNA glycosylase [6, 9 -11] .
An alternate way of preventing carryover contamination is to detect PCR products without opening the reaction tube after amplification. If product detection is by spectroscopic means in a sealed vessel, then the tube can be discarded after analysis, removing the risk of release of amplicon. Another advantage is that homogeneous amplicon detection avoids electrophoretic separations and should be easily adaptable to automated analysis.
Fluorescence polarization (FP) detects changes in the molecular volume of a fluorophore [12] and is also capable of detecting nucleic acid hybrids in solution (A. J. Garman, Zeneca Pharmaceuticals, personal communication, [13] [14] [15] [16] ). 1 We show that there is a measurable increase in the FP of a fluorescently labeled oligonucleotide probe when specifically hybridized to a PCR amplicon.
The amplification refractory mutation system (ARMS ) is a powerful technique for detecting mutations and polymorphisms in DNA [17] and is in part a significant improvement of the PCR. Primers that are mismatched at their 3Ј termini relative to the template genomic DNA are not readily extended by, e.g., Taq DNA polymerase. Two ARMS reactions are usually performed on a DNA sample. These involve primer sets that contain a common primer in both reactions and a primer specific for one or the other allele in the separate reactions. The three possible results, depending on the genotype, are: (a) DNA that is homozygous for one allele gives a product in the reaction with the primer specific for that allele, (b) DNA from a homozygote for the other allele gives a product with the other allele-specific primer, and (c) there is product in both of the reactions when DNA from a heterozygote is tested. Here, we demonstrate that the inclusion of a fluorescently labeled probe with the ARMS primers allows the homogeneous genotyping of DNA samples. Detection of the ARMS products is achieved by measuring the change in FP of the probe bound to the amplicon. Because the sequence of the amplicon produced by each test differs only at the location of the allelic variation, one fluorescent probe can be used to detect both amplicons. To demonstrate the use of FP in the homogeneous detection of ARMS products we adapted an ARMS test for the cystic fibrosis transmembrane conductance regulator (CFTR) gene ⌬F 508 mutation [18] .
Materials and Methods
Instrumentation. FP was measured with the microtiter plate reader Fluorolite FPM-2 (Jolley Research, Round Lake, IL) or a SPEX Fluoromax (SPEX Industries, Edison, NJ) fluorometer modified by the inclusion of polarizing prisms in the excitation and emission light beams. Black microtiter plates suitable for reading fluorescence were from Costar (Cambridge, MA).
Reagents and solutions. PBS and 5-([4,6-dichlorotriazin-2yl]amino)fluorescein (DTAF) were from Sigma Chemical Co., Poole, UK; Sephadex G-25, NAP-10 columns, and dNTPs from Pharmacia Biotechnology, Piscataway, NJ; Taq DNA polymerase (AmpliTaq) from P. E. Applied Biosystems, Foster City, CA; Nusieve agarose from FMC BioProducts, Rockland, ME; and ØX174 DNA/HaeIII digest molecular size marker from Life Technologies, Gaithersburg, MD. All other chemicals were from Aldrich Chemical Co., Milwaukee, WI. Oligonucleotides with the 5Ј labels 6-carboxyrhodamine (ROX), fluorescein, and 6-aminohexylphosphate were from Oswel Research Products (Southampton, UK). The remaining oligonucleotides were synthesized on a P. E. Applied Biosystems 394 DNA/RNA synthesizer with P. E. Applied Biosystems reagents according to the supplier's protocols and were purified by size exclusion filtration through NAP-10 columns. The DTAF labeling buffer was 0.10 mol/L NaCl, 0.10 mol/L sodium carbonate, pH 8.00; HPLC buffer A 0.1 mol/L ammonium chloride; HPLC buffer B 800 mL/L HPLC buffer A, 200 mL/L acetonitrile; ARMS buffer 1.2 mmol/L MgCl 2 , 10 mmol/L Tris-HCl, 50 mmol/L KCl, 0.1 g/L gelatin, pH 8.3; Tris-borate-EDTA electrophoresis buffer (TBE) 134 mmol/L Tris, 74.9 mmol/L boric acid, 2.55 mmol/L EDTA, 0.1 mg/L ethidium bromide; gel loading buffer 300 mL/L glycerol and 1 g/L bromphenol blue in TBE; and PBS 10 mmol/L phosphate, 2.7 mmol/L KCl, 0.137 mol/L NaCl, pH 7.4.
Probe design. Probe sequences were designed with the primer analysis software Oligo 5 (National Biosciences, Plymouth, MN). Specifically, probes were to hybridize to one of the strands of the target amplicon after amplification but not during the extension phase of the PCR. If probes were hybridized during PCR extension they would be degraded by the 5Ј-exonuclease function of Taq DNA polymerase [19] as the enzyme extended the primer annealed to the same strand. Probe sequences were selected to have T m s between 12 and 15°C below the temperature of the PCR extension phase. To facilitate probe hybridization, regions of the gene sequence capable of forming stable secondary structures were rejected as binding sites. An internal structure search was performed for candidate probe sequences plus 10 nucleotides upand downstream. Only sequences that included hairpins with stems of three bp or less and where the ⌬G value for loop formation was ϾϪ1.0 kcal/mol were considered.
Probe labeling. The 6-aminohexylphosphate-labeled oligonucleotide probe was labeled with DTAF as follows: One milliliter of DTAF (500 mg, 940 nmol) in a mixture of acetonitrile and PBS (1:1 by vol) was added to probe 1 (Table 1) (21.3 nmol) in DTAF labeling buffer (500 L). After 1 h the reaction was quenched by adding diisopropylamine (10 mg, 10 mmol) and separated on Sephadex G-25 (15 mm ϫ 400 mm) eluted in water. The faster eluting fraction was resolved by reversed-phase HPLC [Waters bondapak C18 (Waters Corp., Milford, MA) gradient elution profile with buffers A and B: time 0 min (100% HPLC buffer A, 0% HPLC buffer B), 2.5 min (100% A, 0% B), 7.5 min (0% A, 100% B), 13 min (0% A, 100% B), Several yellow-colored peaks were obtained and desalted on Sephadex G-25 as above. One peak gave a short retention time and was designated probe 2. This was confirmed to be the DTAF-labeled oligonucleotide (UV max 260 nm with minor peak at 495 nm). In addition, the FP of free probe 2 ϭ 51 mP, FP of probe 2 annealed to excess probe 3 ϭ 170 mP.
DNA samples. ⌬F 508 /⌬F 508 and ⌬F 508 /ϩ cell line DNA were obtained from the Coriell Institute for Medical Research (Camden, NJ), and ϩ/ϩ DNA was isolated from peripheral blood leukocytes from an unaffected individual as described previously [18] . Each sample was diluted to a concentration of 10 mg/L (10 ng L Ϫ1 ) before use. The mutant allele was amplified with primers 1 and 2; the normal allele was amplified with primers 1 and 3. Primers 4 and 5 were included in both reactions to generate an apolipoprotein (apo) B gene amplification control amplicon. All primers ( Table 2) were used at a concentration of 1 mol/L; the PCR mixes included dNTPs (100 mol/L each) and probe (30 nmol/L) in ARMS buffer (150 L total volume). DNA (150 ng) and a mineral oil overlay were added. The samples were heated at 94°C for 5 min; then Taq DNA polymerase (3 U) was added. Thirty-five rounds of thermal cycling were carried out (94°C 1 min, 58°C 1 min, 72°C 1 min). An aliquot (10 L) was removed after PCR for gel analysis and the remainder was examined by FP.
Gel electrophoresis. Three percent gels (Nusieve agarose: agarose, 3:1) were prepared and electrophoresed in TBE buffer. ARMS reaction aliquots were mixed with gel loading buffer (10 L) and electrophoresed against ØX174/HaeIII digest DNA size markers (500 ng). Gels were visualized by UV transillumination and photographed.
FP. FP probes were annealed to the target amplicon by heating at 94°C for 5 min, snap cooling on ice for 5 min, and equilibrating at 25°C for 30 min. The samples were then either transferred to a black microtiter plate for automated reading on the Fluorolite FPM-2 or were transferred to quartz microcuvettes (100 L) for manual reading on the Fluoromax. Fluorescein-and DTAF-labeled probes were excited at 495 nm and the fluorescence was detected at 525 nm; ROX-labeled probes were excited at 585 nm and the fluorescence was detected at 605 nm.
Four fluorescence readings were taken to calculate FPs: I VV , reading with excitation and emission polarizers vertical; I VH , reading with excitation polarizer vertical and emission polarizer horizontal; I HV , reading with excitation polarizer horizontal and emission polarizer vertical; and, I HH, reading with excitation and emission polarizers horizontal.
G ϭ I HV /I HH The G value is a correction factor that allows for the different light transmission characteristics of the two polarizers in the vertical and horizontal orientations. FPs are quoted as mP values.
Results
Genotyping by ARMS and FP. We designed a homogeneous ARMS test to analyze the ⌬F 508 and F 508 (ϩ) alleles of the CFTR gene [20] . A panel of DNAs (ϩ/ϩ, ϩ/⌬F 508 , and ⌬F 508 /⌬F 508 ) were used to generate ARMS amplicons [18] in the presence of fluorescein-labeled probe 5. Control reactions with no DNA were also run (see Fig. 1 ). An apo B-derived amplification control product was also generated with primers 4 and 5 but was not detected by FP. Gel electrophoresis of aliquots of the ARMS reactions showed amplicons of the expected size in all lanes; no additional products were seen (see Fig. 1 ). The remainder of the ARMS reactions were subjected to a heat-cool cycle to anneal probe 5 to the ARMS amplicons and the FP of the probe was determined on the SPEX Fluoromax for each of the 24 samples. The results are shown in Fig. 2 . The positive samples give a mean FP of 99 mP (n ϭ 12, SD 2.4); the negative samples give a mean FP of 68 (n ϭ 12, SD 2.1). By using a t-distribution test, t ϭ 32.3 for these data sets. For 22 degrees of freedom t 0.95 ϭ 1.72 and t 0.99 ϭ 2.51, which shows that the mean FPs of the two data sets are significantly different at a 99% level of confidence. A 99% confidence interval, rounded outwards, for a future observation from the positive sample population is (91, 107; 99 Ϯ 8), and similarly from the negative sample population is (61, 75; 68 Ϯ 7). These intervals do not overlap and therefore demonstrate a clear separation between the two populations (see Fig. 3 ).
Multiplex detection of amplicons.
Simultaneous detection of several fluorophores in a mixture is possible by selecting fluorophores with discrete excitation and emission fre- probes were used in three amplification mixes whereby the first contained both the ARMS and apo B products, the second only the ARMS product, and the third only the apo B product. Each experiment was in duplicate. The average FP of each probe in each amplification mixture is shown in Fig. 4 . These results show that the two FP probes can be used to detect their target amplicons in the same solution.
Stability of probe-product hybrids and specificity of hybrid formation. Probe 2 was annealed to both the ARMS and apo B amplicons and the time course of the change in FP of the probe was monitored on the FPM-2 as shown in Fig.  5 . Hybridization of the probe to the apo B amplicon was not observed. These data demonstrate that the probe Fig. 3 . FP readings from the ARMS reactions from Fig. 2 showing the clustering of the FP values around the mean values for negative and positive reactions. anneals to its target selectively where it forms a stable hybrid.
Discussion
The ratio of bound probe to unbound probe in a sample can be determined by FP. Maximal differences in FP values are obtained between samples that contain no bound probe and those in which all of the probe is bound to its target. Thus, FP can be used as a complementary technique to PCR to detect the generation of an amplicon. In ARMS, amplification efficiency is dramatically reduced when a primer is mismatched at the 3Ј terminus relative to the genomic target. Only when primers are matched to the genomic target is a detectable amplicon generated. Detection of a mutation is therefore reduced to simply determining whether or not a sample contains an amplicon because its generation of an amplicon is dependent on the genomic DNA sequence. For FP detection the threshold concentration of product is dependent on the probe concentration. Sufficient target needs to be formed for all of the probe to be able to bind to avoid a mixture of bound and unbound probe. In such a situation there would be lower net FP than in a sample in which the probe was entirely bound. A partially bound sample is still usually distinguishable from an unbound sample but there will be a diminution in the separation of the polarizations of the positive and negative samples. For this reason we set the probe concentration below the expected concentration of any product formed. If only low concentrations of diagnostic ARMS amplicon are formed, giving a low FP, we would expect that a correspondingly small amount of amplification control would be formed. Such a sample would be identified as an amplification failure by reference to the FP of the control probe rather than as a negative sample that could lead to a misdiagnosis.
FP is determined by the measurement of fluorescence intensities. The higher the probe concentration, the more accurate the measurement; lower probe concentrations favor reproducible amplicon detection. Optimum probe concentrations therefore reflect this relation between accuracy and reproducibility. We found that for ARMS reactions generating two amplicons, a probe concentration of 30 nmol/L is ideal. With primer sets at a concentration of 1 mol/L, only 3% of primers require conversion to amplicon to produce target at 30 nmol/L. We found that in such reactions the amount of primer incorporated into amplicon is usually between 5% and 10% (data not shown). A 30 nmol/L probe concentration will therefore give a reproducible change in FP in almost all test samples. In Fig. 4 (top) the difference in FPs for the two positive samples detected by the apo B probe is probably due to a low yield of apo B amplicon. This would result in a significant proportion of probe remaining unhybridized, thereby lowering the net FP value. Thus, samples that give product at Ͻ30 nmol/L will usually be detectable, but samples in which the amplicon concentration is Ͻ10 nmol/L will be difficult to distinguish from negatives and would be identified as amplification failures to be retested.
Although FP can be used quantitatively [16] , it is also suited to delivering simple "yes or no" answers as is shown in Fig. 2 . Twelve of the samples contain the ARMS amplicon, 12 do not. FP clearly differentiates between the two groups with little variation about their respective mean FP. It is important to determine if there is an overlap of the data sets. We have shown that the two data sets are distinct and therefore misdiagnoses should be avoided.
FP detection of PCR amplification is reliant on the hybridization of an oligonucleotide probe to one strand of a denatured PCR product. There are two competing equilibria in such a reaction. These are the binding of the probe to one of the amplicon strands and the reannealing of the two amplicon strands. The thermodynamically more stable state for the system is for the PCR product to reanneal, leaving the probe unbound. However, the rate of DNA duplex formation varies with the square root of the length of the smaller strand forming the duplex [21] . The binding of the probe to one of the amplicon strands is therefore kinetically favored over the reannealing of the two amplicon strands as is shown in Fig. 5 . This Fig. also shows that the specificity of the reaction is very high. To detect a mutation by ARMS with FP, there must be three specific oligonucleotide annealing events: the binding of the two PCR primers to the genome to generate the amplicon, followed by the binding of the fluorescently labeled probe to an internal region of that amplicon. Thus an amplified region of the genome will only give rise to a positive FP result if it contains a sequence complementary to that of the probe. The chance of such a region being amplified by random priming off the genome is essentially zero. Nevertheless, confirming the specificity of the first two hybridization events in the development of an ARMS/FP assay might be considered prudent. This is conveniently done by monitoring the ARMS part of the assay with gel electrophoresis as we described.
Our results show that fluorescein, DTAF, and ROX are useful for the FP detection of PCR products, and we demonstrated the multiplexed detection for two amplicons using the two latter fluorophores. Other chromophores can be used to label probes, including 6-carboxy-2Ј, 7Јdimethoxy-4Ј, 5Јdichlorofluorescein (JOE) and Cy-5 (data not shown). A wide range of the visible spectrum that forms the basis of a powerful multiplex detection capability is covered by these dyes.
In conclusion, we have demonstrated simple, rapid, and reproducible genotyping of DNA samples using FP detection of ARMS amplicons. The detection protocol requires a postamplification heat, cool, and equilibration cycle. Reading is rapid with the microtiter plate reader FPM-2, although this instrument is not suitable for carrying out multiplex detection. The technique can be considered homogeneous in that it requires no separation or wash step, but, in the multiplex format, it must be carried out in a nonhomogeneous manner because the ARMS reactions must be transferred from one vessel to another for the FP measurement. Therefore, for homogeneous multiplex ARMS analyses with FP, a microtiter FP plate reader is needed with two novel features: (a) multiple label detection across the entire visible spectrum, and (b) the ability to carry out assays directly on samples contained in PCR amplification tubes or microplates. This would lend the system to automation and completely obviate the need for complex means of avoiding carryover contamination [3] [4] [5] [6] [7] [8] [9] [10] [11] .
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